Gregory Hanson Net Worth & Insider Trades
Gregory Hanson - CHIEF FINANCIAL OFFICER, Mabvax Therapeutics Holdings, Inc
What is Gregory Hanson's Net Worth?
The current estimated net worth of Mabvax Therapeutics Holdings, Inc's CHIEF FINANCIAL OFFICER, Gregory Hanson, is estimated to be about $168.97K . Gregory Hanson owns about 38,334 units of Mabvax Therapeutics Holdings, Inc common stock. In the last year at Mabvax Therapeutics Holdings, Inc, Gregory Hanson has sold an estimated value of $17.86K worth.
What is Gregory Hanson's Past Insider Trading?
Gregory Hanson's largest purchase order was 9,128 units , worth over $7.5K on August 2, 2017. Gregory Hanson's largest sale order was 3,667 units , worth over $7.98K on April 6, 2017. In total, Gregory Hanson has made about 7 transactions over a year of their time at Mabvax Therapeutics Holdings, Inc. Gregory Hanson usually trades in April, with the busiest year in 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gregory P Hanson
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Gregory Hanson's' Mailing Address?
- Mailing address is Mabvax Therapeutics Holdings, Inc. 11588 Sorrento Valley Road Suite 20 San Diego CA 92121 CA
What are Mabvax Therapeutics Holdings, Inc's Past Insider Trades?
Mabvax Therapeutics Holdings, Inc's most recent insider trade came on January 24, 2018 by Jeffrey Eisenberg who sold 35,442 units worth $30.29K . In the last 3 years, insiders at Mabvax Therapeutics Holdings, Inc have sold an estimated value of $841.22K and bought an estimated value of $39.55K worth of shares. Insider trading is most common in April, with the busiest year in 2017. The most active traders at the company are J. David Hansen, PRESIDENT AND CEO, Gregory P Hanson, CHIEF FINANCIAL OFFICER, and Paul W Maffuid, EXEC. VP .
MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |